- Earth Science Tech recently completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products
- The acquisition delivers value across three growth drivers, including expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market
- The acquisition represents Earth Science Tech’s move to seize strategic opportunities that broaden the company’s telehealth and pharmacy fulfillment platforms into new, complementary verticals
Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently acquired Zoolzy LLC. Based in Doral, Florida, where it operates from a 3,684-square-foot facility, Zoolzy is a wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products (https://ibn.fm/vcqkE).
The acquisition complements and supports ETST’s compounding pharmacies by enabling them to secure essential raw materials at highly competitive wholesale pricing, significantly increasing the company’s overall profit margins. It also expands ETST’s supply network, broadening access to novel, highly sought-after APIs to increase its custom compounding capabilities.
Additionally, the acquisition gives Earth Science Tech immediate, strategic procurement access to common veterinary medications, enabling the company to expand into the animal health market. Through this new, high-margin vertical, ETST will focus on formulating unique, flavored, and easy-to-administer veterinary therapeutics.
The highly accretive acquisition of Zoolzy is the latest in Earth Science Tech’s strategic investments to catalyze immediate growth and deliver financial and operational value to shareholders. It follows the acquisition of La Verne, California-based Meduvo LLC, a compounding pharmacy whose addition to ETST’s fold established a highly strategic West Coast operational hub and expanded its network to 34 U.S. jurisdictions (https://ibn.fm/ChJUS).
“Looking ahead, we are focused on scaling the business by expanding our geographic footprint, advancing our telehealth and pharmacy fulfillment platforms, and building long-term, sustainable shareholder value,” committed Giorgio R. Saumat, CEO and Chairman of the Board, during the release of the company’s fiscal first quarter 2027 financial results (https://ibn.fm/2BOyR).
The results continued trend from fiscal 2026, in which all key operating subsidiaries achieved profitability. Still, the company said management remains focused on actively evaluating strategic opportunities to broaden its telehealth and pharmacy fulfillment platforms into new, complementary verticals. The completion of the Zoolzy acquisition, therefore, reflects the Earth Science Tech’s execution of its management’s commitment.
For more information, visit the company’s website at www.EarthScienceTech.com.
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
